FDA greenlights GSK’s drug for UTIs in women and girls
The FDA approved GSK’s drug for a common type of urinary tract infection (UTI) in women and adolescent girls, one of five new ...
Fierce Pharma11h
GSK ushers in new UTI antibiotic with FDA nod for first-in-class Blujepa
GSK is opening the door to a new era in urinary tract infection (UTI) treatment with its Blujepa, the first in a new class of ...
US FDA approves GSK's 'Blujepa' for treating UTIs in women and girls
The approval was based on data from two late-stage trials showing the drug was superior to nitrofurantoin, the ...
US FDA approves GSK's urinary tract infection drug
The U.S. Food and Drug Administration on Tuesday approved GSK's drug for a common type of urinary tract infection (UTI) in ...
US FDA greenlights GSK's drug for UTIs in women and girls
The U.S. Food and Drug Administration on Tuesday approved GSK's drug for a common type of urinary tract infection (UTI) in ...
The Cardiology Advisor16h
RSV Linked to High Burden of Hospitalizations Prior to Vaccine Availability
Among adults aged 75 and older, RSV was linked to a substantial burden of hospitalizations, ICU admissions, and in-hospital deaths before vaccines were available.